Scinovex
article Open AccessTop 1% cited

Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register

Journal of Neurology Neurosurgery & Psychiatry · 2005 · Vol. 77(2) · pp. 193–198
James Morrow

Abstract

Only 4.2% of live births to women with epilepsy had an MCM. The MCM rate for polytherapy exposure was greater than for monotherapy exposure. Polytherapy regimens containing valproate had significantly more MCMs than those not containing valproate. For monotherapy exposures, carbamazepine was associated with the lowest risk of MCM.

Pharmacological Effects and Toxicity StudiesPregnancy and Medication ImpactEpilepsy research and treatmentLamotrigineCarbamazepineEpilepsyMedicinePregnancyOdds ratioProspective cohort studyConfidence intervalObstetricsPediatrics

MeSH terms

AnticonvulsantsDose-Response Relationship, DrugDrug Therapy, CombinationEpilepsyFemaleFollow-Up StudiesGestational AgeHumansInfant, NewbornPregnancyPregnancy ComplicationsPregnancy OutcomeProspective StudiesRegistriesRisk

Funding

  • Pfizer
  • Sanofi
  • Epilepsy Action
  • Epilepsiatutkimussäätiö
  • Cilag
Citations
877
FWCI
82.75
field-weighted impact
References
46
Percentile
100%
vs. same field & year
Citations per year
Cited by
Practice Bulletin No. 183: Postpartum Hemorrhage
Obstetrics and Gynecology · 2017 · 1,305 citations
References
Probable Inference, the Law of Succession, and Statistical Inference
Journal of the American Statistical Association · 1927 · 3,590 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register · Scinovex